Understanding how microRNAs can help treat osteoarthritis in older adults
Novel Mechanisms Of MicroRNA-Mediated Anabolic Effects In Age-Related Osteoarthritis
This study is looking at tiny molecules called microRNAs that might help keep your joints healthy and support healing in older adults with osteoarthritis, especially in the ankle and hip, to find new ways to improve treatment for this condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11010035 on NIH RePORTER |
What this research studies
This research investigates the role of microRNAs in promoting joint health and regeneration in older adults suffering from osteoarthritis (OA). The study focuses on identifying specific microRNAs present in human cartilage and their relationship with joint health, particularly in the ankle and hip. Researchers will analyze how these microRNAs are influenced by age and how they can potentially enhance the anabolic processes in cartilage through various signaling pathways. By understanding these mechanisms, the research aims to develop new therapeutic strategies for OA.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those over the age of 50, who are experiencing symptoms of osteoarthritis.
Not a fit: Patients who are younger than 50 or do not have osteoarthritis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that improve joint health and reduce pain for older adults with osteoarthritis.
How similar studies have performed: Previous research has shown promising results in using microRNAs for joint health, indicating that this approach has potential for success.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Hsueh, Ming-Feng — Univ of North Carolina Chapel Hill
- Study coordinator: Hsueh, Ming-Feng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.